Aim of this study has been to evaluate the prevalence of arterial hype
rtension and other risk factors in patients suffering with PAD in two
clinical samples (l.: 102 patients with PAD, 69 M, 33 F, studied in ou
r angiology laboratory, matched for sex and age with 102 healthy volun
teers; 2.: 184 hospitalized patients, 80 M, 104 F, mean age 57.2+/-10.
8, with PAD) and in two epidemiological studies (l.: Trabia Study, 835
subjects; and 2.: Casteldaccia Study, 723 subjects). All patients per
formed a full clinical and laboratory examination, including the deter
mination of the ankle/arm pressure ratio (Winsor index, positive for P
AD when lower than 0.95). In the first clinical study we observed a si
gnificantly (p<0.01) greater prevalence of arterial hypertension (51.9
vs 9.8%), hypercholesterolemia ( 48.2 vs 21.6%), hypertriglyceridemia
(53.7 vs 26.1%), smoking habit (64.3 vs 44.2%), and hyperglycemia (26
vs 7.9%) in PAD patients than in controls. In the second clinical stu
dy, considering separately the patients under and over 65 years, all r
isk factors resulted more prevalent in younger people than in the aged
, except diabetes and hypertension. In our epidemiological experience,
the prevalence of PAD increases with aging, above all in males. In th
e Trabia study the risk factors more associated with PAD have been hyp
ercholesterolemia, smoking and obesity (41.18%) in males and hypertens
ion and hypercholesterolemia (33.3%) and obesity (25%) in females. In
the Casteldaccia Study the most important risk factors have been smoki
ng habit (64.28%), hypercholesterolemia ( 42.86%) and hypertriglycerid
emia (35.71%) in males, and obesity (60%), hypercholesterolemia (30%)
and diabetes (20%) in females. Cholesterol levels and smoking habit ha
ve been significantly higher in PAD patients than in general populatio
n, whereas hypertriglyceridemia and glycemia did not. Arterial hyperte
nsion has been significantly associated with PAD in the Trabia Study,
but not in the Casteldaccia one. Obesity has been significantly associ
ated to PAD in females in both study. In the Casteldaccia Study, lower
HDL-cholesterol levels have been observed in PAD patients, above all
males, whereas significantly greater Apo-B values and lower Apo-Al lev
els (in males) have been shown. The different levels of associated ris
k factors and their prevalence in PAD patients confirm the multifactor
ial pathogenesis of atherosclerosis. The exact role of each risk facto
r in the genesis of PAD is difficult to evaluate due to the complex bi
ological and statistical interrelationships among different risk facto
rs. However, the management of associated risk factors may favourably
influence the risk profile in each patient suffering with PAD.